Skip to content
10-Q

Quarterly Report

Omega Therapeutics, Inc.

0000950170-24-127008

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 8, 2024 55.37M sh
Shares Diluted Q3 2024 · Sep 30, 2024 55.16M sh
Shares Diluted Q3 2024 · Sep 30, 2024 55.15M sh
Shares Diluted Q3 2024 · Sep 30, 2023 55.14M sh
Shares Diluted Q3 2024 · Sep 30, 2023 53.63M sh
Capex Q3 2024 · Sep 30, 2024 $947K
Capex Q3 2024 · Sep 30, 2023 $1.76M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$38.49M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$74.42M
Long Term Debt Q3 2024 · Sep 30, 2024 $11.59M
Long Term Debt Q3 2024 · Dec 31, 2023 $14.89M
Short Term Debt Q3 2024 · Sep 30, 2024 $4M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $30.38M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $68.44M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $81.77M
Stockholders Equity Q3 2024 · Sep 30, 2024 $11.54M
Stockholders Equity Q3 2024 · Jun 30, 2024 $26.26M
Stockholders Equity Q3 2024 · Mar 31, 2024 $41.35M
Stockholders Equity Q3 2024 · Dec 31, 2023 $58.02M
Stockholders Equity Q3 2024 · Sep 30, 2023 $76.04M
Stockholders Equity Q3 2024 · Jun 30, 2023 $95.92M
Stockholders Equity Q3 2024 · Mar 31, 2023 $123M
Stockholders Equity Q3 2024 · Dec 31, 2022 $105.97M
Current Liabilities Q3 2024 · Sep 30, 2024 $24.17M
Current Liabilities Q3 2024 · Dec 31, 2023 $26.81M
Total Liabilities Q3 2024 · Sep 30, 2024 $141.18M
Total Liabilities Q3 2024 · Dec 31, 2023 $146.35M
Current Assets Q3 2024 · Sep 30, 2024 $38.95M
Current Assets Q3 2024 · Dec 31, 2023 $89.88M
Total Assets Q3 2024 · Sep 30, 2024 $152.73M
Total Assets Q3 2024 · Dec 31, 2023 $204.37M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.30
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.96
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.40
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.44
Eps Basic Q3 2024 · Sep 30, 2024 −$0.30
Eps Basic Q3 2024 · Sep 30, 2024 −$0.96
Eps Basic Q3 2024 · Sep 30, 2023 −$0.40
Eps Basic Q3 2024 · Sep 30, 2023 −$1.44
Sga Expense Q3 2024 · Sep 30, 2024 $6.23M
Sga Expense Q3 2024 · Sep 30, 2024 $19.4M
Sga Expense restated Q3 2024 · Sep 30, 2023 $7.23M
Sga Expense restated Q3 2024 · Sep 30, 2023 $20.03M
Rd Expense Q3 2024 · Sep 30, 2024 $12.81M
Rd Expense Q3 2024 · Sep 30, 2024 $41.16M
Rd Expense restated Q3 2024 · Sep 30, 2023 $16.51M
Rd Expense restated Q3 2024 · Sep 30, 2023 $61.64M
Net Income Q3 2024 · Sep 30, 2024 −$16.44M
Net Income Q3 2024 · Sep 30, 2024 −$52.88M
Net Income Q3 2024 · Jun 30, 2024 −$16.31M
Net Income Q3 2024 · Mar 31, 2024 −$20.13M
Net Income Q3 2024 · Sep 30, 2023 −$22.25M
Net Income Q3 2024 · Sep 30, 2023 −$77.21M
Net Income Q3 2024 · Jun 30, 2023 −$29.69M
Net Income Q3 2024 · Mar 31, 2023 −$25.28M
Operating Income Q3 2024 · Sep 30, 2024 −$16.42M
Operating Income Q3 2024 · Sep 30, 2024 −$53.45M
Operating Income Q3 2024 · Sep 30, 2023 −$22.9M
Operating Income Q3 2024 · Sep 30, 2023 −$79.56M